This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mao, X. Articles by Ghosh, H. P. Search for Related Content PubMed PubMed Citation Articles by Mao, X. Articles by Ghosh, H. P.

The Cytoplasmic Domain Is Critical to the Tumor Suppressor Activity of TSLC1 in Non-Small Cell Lung Cancer

¹ Department of Biochemistry, McMaster University, Hamilton, Ontario, Canada;
² Hamilton Regional Cancer Center, Hamilton, Ontario, Canada;
³ Tumor Suppression and Functional Genomics Project, National Cancer Center Research Institute, Tokyo, Japan

The tumor suppressor gene in lung cancer (TSLC1) encodes a membrane glycoprotein containing extensive homology in the extracellular domain with the immunoglobulin-superfamily cell adhesion molecules. The intracellular cytoplasmic domain (CT) contains a protein 4.1 (FERM) binding motif, and a PDZ-interacting motif. Expression of TSLC1 is silenced in non-small cell lung cancer and in other cancers by promoter hypermethylation. Restoration of TSLC1 expression suppresses tumorigenicity of lung cancer cells. We report here the critical role of the FERM-binding and PDZ- interacting domains of TSLC1 in tumor suppressor activity in non-small cell lung cancer. The entire CT domain [amino acid (aa) 398–442], the FERM binding motif (aa 398–410), or the PDZ-interacting motif (aa 432–442) was deleted to generate mutants CT1, CT3, and CT4, respectively. The lung cancer cell line A549, deficient in TSLC1 expression, was stably transfected with the wild-type TSLC1 or the deletion mutants. The cell lines were then injected into athymic (nu/nu) nude mice, and tumor formation at the sites of injection was monitored. A549 cells stably transfected with the empty vector or mutant TSLC1 constructs induced tumors at the sites of injection within 10 days. In contrast, A549 cells expressing wild-type TSLC1 showed the appearance of tumors after 35 days, and the tumors grew substantially slower. A549 cells expressing wild-type TSLC1 also showed suppression of anchorage-independent colony formation in soft agar and markedly increased cell-cell adhesion activity. These results suggest that the cytoplasmic domain of TSLC1 is important in its tumor suppressor activity, and the tumor suppression activity involve protein(s) interacting with the FERM- and PDZ-interacting regions.

This article has been cited by other articles:

				A. Giangreco, K. B. Jensen, Y. Takai, J. Miyoshi, and F. M. Watt Necl2 regulates epidermal adhesion and wound repair Development, October 15, 2009; 136(20): 3505 - 3514. [Abstract] [Full Text] [PDF]

				S. Kawano, W. Ikeda, M. Kishimoto, H. Ogita, and Y. Takai Silencing of ErbB3/ErbB2 Signaling by Immunoglobulin-like Necl-2 J. Biol. Chem., August 28, 2009; 284(35): 23793 - 23805. [Abstract] [Full Text] [PDF]

				S. M. Reamon-Buettner and J. Borlak Epigenetic Silencing of Cell Adhesion Molecule 1 in Different Cancer Progenitor Cells of Transgenic c-Myc and c-Raf Mouse Lung Tumors Cancer Res., September 15, 2008; 68(18): 7587 - 7596. [Abstract] [Full Text] [PDF]

				N. Wakamatsu, J. B. Collins, J. S. Parker, M. Tessema, N. P. Clayton, T.-V. T. Ton, H.-H. L. Hong, S. Belinsky, T. R. Devereux, R. C. Sills, et al. Gene Expression Studies Demonstrate that the K-ras/Erk MAP Kinase Signal Transduction Pathway and Other Novel Pathways Contribute to the Pathogenesis of Cumene-induced Lung Tumors Toxicol Pathol, July 1, 2008; 36(5): 743 - 752. [Abstract] [Full Text] [PDF]

				E. I. Surace, A. Strickland, R. A. Hess, D. H. Gutmann, and C. K. Naughton Tslc1 (Nectin-Like Molecule-2) Is Essential for Spermatozoa Motility and Male Fertility J Androl, November 1, 2006; 27(6): 816 - 825. [Abstract] [Full Text] [PDF]

				L. van der Weyden, M. J. Arends, O. E. Chausiaux, P. J. Ellis, U. C. Lange, M. A. Surani, N. Affara, Y. Murakami, D. J. Adams, and A. Bradley Loss of TSLC1 Causes Male Infertility Due to a Defect at the Spermatid Stage of Spermatogenesis. Mol. Cell. Biol., May 1, 2006; 26(9): 3595 - 3609. [Abstract] [Full Text] [PDF]

				M. Masuda, S. Kikuchi, T. Maruyama, M. Sakurai-Yageta, Y. N. Williams, H. P. Ghosh, and Y. Murakami Tumor Suppressor in Lung Cancer (TSLC)1 Suppresses Epithelial Cell Scattering and Tubulogenesis J. Biol. Chem., December 23, 2005; 280(51): 42164 - 42171. [Abstract] [Full Text] [PDF]

				L. Galibert, G. S. Diemer, Z. Liu, R. S. Johnson, J. L. Smith, T. Walzer, M. R. Comeau, C. T. Rauch, M. F. Wolfson, R. A. Sorensen, et al. Nectin-like Protein 2 Defines a Subset of T-cell Zone Dendritic Cells and Is a Ligand for Class-I-restricted T-cell-associated Molecule J. Biol. Chem., June 10, 2005; 280(23): 21955 - 21964. [Abstract] [Full Text] [PDF]